As the company heads into its first-quarter earnings report, the narrative has changed from last year's struggles.
Pre-Market Stock Futures: The futures are exploding higher, as, fortunately, President Trump chose not to "end civilization in Iran" and agreed to a two-week pause on attacks on Iran. In contrast, Ira
Braun Stacey Associates Inc. lifted its stake in shares of Johnson and Johnson (NYSE: JNJ) by 9.9% in the undefined quarter, according to the company in its most recent 13F filing with the Securities
Dow Jones medical giant Johnson & Johnson, along with AstraZeneca, Burlington Stores and TJX, are in or near buy zones Tuesday.
IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson announced launch of VARIPULSE Pro in Europe following CE Mark approval, further advancing its pulsed field ablation (PFA) portfolio.
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Coca-Cola (NYSE:KO) both closed out 2025 with Q4 earnings and have raised dividends for 63 consecutive years.
A safe stock is a business that can take a punch, keep generating cash flow, keep paying shareholders, and still look stronger a few years later. When debt is low, management has room to maneuver. It
Aberdeen Group plc lifted its stake in Johnson and Johnson (NYSE: JNJ) by 1.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,538,4
HF Advisory Group LLC boosted its holdings in Johnson and Johnson (NYSE: JNJ) by 305.9% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchang
Johnson & Johnson earns a Buy rating, driven by the FDA approval of its Tecvayli and Darzalex Faspro combination for R/R multiple myeloma, delivering best-in-class efficacy. This combination therapy a
Defensive healthcare stocks such as Johnson & Johnson and CVS tend to outperform in recessions. Growth healthcare stocks offer higher risk and potential reward, less tied to economic cycles.
Bourgeon Capital Management LLC grew its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 97.4% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchan
Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in Johnson and Johnson (NYSE: JNJ) by 14.4% during the undefined quarter, according to the company in its most recent
Econ Financial Services Corp lowered its position in shares of Johnson and Johnson (NYSE: JNJ) by 87.5% during the fourth quarter, according to its most recent disclosure with the Securities and Excha
BTC Capital Management Inc. reduced its position in Johnson and Johnson (NYSE: JNJ) by 5.4% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 91,064 shares of
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE